A heritage-rich one started nearly 50 years ago with a vision to facilitate access to trusted medicines in terms of efficacy and safety.
Dar Aldawa is a leading pharmaceutical company dedicated to serving patients and the medical community across the world.
Dar Aldawa aims to become the foremost pharmaceutical partner for key stakeholders keen on improving health outcomes, cost of care, and the well-being of patients and their caregivers.
Announcement to the esteemed shareholders of DAR Al DAWA Development and investment public Shareholding company Invitation to attend the Ordinary and Extraordinary-General Assembly Meetings
The Board Of Directors of (Dar Al Dawa Company For Development And investment PIc) Is Honored To invite you To Attend The 49th Ordinary General Assembly Meeting, Which Will Be Held At (12:00 noon On Thursday, April 24, 2025) to be followed immediately by an Extraordinary -General Assembly Meeting . These meetings will be conducted virtually via video conferencing (Zoom) , As Per The Approval Of The (Minister of industry Trade and Supply) , in order to consider the items listed on the agenda that have been published on the company's website and on the companies control department's website . Shareholders are kindly requested to register for the above-mentioned meetings and review all related documents.
Dar Aldawa is a
leading
pharmaceutical
company
dedicated to
serving patients,
healthcare
professionals
and payers
across the world.
Vision
Dar Aldawa aims to become the foremost pharmaceutical partner for key stakeholders keen on improving health outcomes, cost of care, and the well-being of patients and their caregivers.
